PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 26, 2026Journal of Medical Case Reports0 citationsOpen Access

A fatal pediatric case of febrile ulceronecrotic Mucha–Habermann disease: diagnostic and therapeutic challenges: a case report

SASoheila AlyasinZKZahra KanannejadAAAlireza Abbasi

Key Points

  • The aim is to describe a rare pediatric case of fatal FUMHD and its diagnostic challenges.
  • Reported case of a 15-month-old boy with rapidly progressing ulceronecrotic lesions and systemic symptoms.
  • Diagnosis confirmed through skin biopsy.
  • Treatment included methylprednisolone, intravenous immunoglobulin, and a TNF-α inhibitor.
  • Disease progressed despite treatment, leading to a fatal outcome.
  • This case represents the youngest documented fatal instance of FUMHD.
  • Challenges include early diagnosis and risk of systemic infection, with limited treatment options.

Abstract

Febrile ulceronecrotic Mucha–Habermann Disease (FUMHD) is a rare and severe form of pityriasis lichenoides et varioliformis acuta. It presents rapidly with ulcerative and necrotic lesions, fever, and systemic symptoms. This condition is associated with significant morbidity and can be extremely dangerous. The exact cause of FUMHD is not well understood, but hypersensitivity reactions may trigger it. We describe a 15-month-old Iranian boy who developed rapidly progressing ulceronecrotic skin lesions accompanied by high-grade fever and systemic involvement. A skin biopsy confirmed a diagnosis of FUMHD. Despite treatment with methylprednisolone, intravenous immunoglobulin, and a TNF-α inhibitor, the disease was fatal. To our knowledge, this represents the third reported fatal case of FUMHD in children and the youngest case documented to date. This report presents the youngest known pediatric case of fatal FUMHD, highlighting the challenges of early diagnosis, risk of systemic infection, and limited treatment options. Early immunosuppressive and antimicrobial therapies are crucial, but prognosis remains poor in aggressive cases.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Alyasin et al. (2026) studied this question.

synapsesocial.com/papers/6a153b00b5d9c58d83e8d310https://doi.org/10.1186/s13256-026-06098-5
Ask AI
Helpful
Bookmark
Share
View Full Paper